Truist raised the firm’s price target on Markel to $1,600 from $1,400 and keeps a Hold rating on the shares after its Q1 results. The firm is citing the company’s improved Insurance segment profitability as well as higher investment income, the analyst tells investors in a research note. Truist adds however that while Markel’s recent acquisitions should prove to be accretive in the long run, there may be some integration challenges along the way.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKL: